Skip to content
GLP-1 Savers
Menu
Ranked #427 · Watch List

myRocky review

myRocky is a Canadian-incorporated multi-product telehealth platform (Rocky Health Inc., Ontario) that markets brand-name GLP-1s — Ozempic, Mounjaro, and Wegovy — to US patients, with no compounded products.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $1,409/mo

From $1,409/mo (2 mg dose, brand-name)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose, and the price is not shown until after you complete an intake.

How much does myRocky cost?

The price myRocky publishes is From $1,409/mo (2 mg dose, brand-name). We flag this one to watch: confirm the ongoing rate with myRocky before you count on it, because a low first month can step up afterward.

Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

The Value Score card

myRocky scored on our six published factors. See the methodology.

Lowest Real Price20/100
No Teaser-Rate Bait38/100
Nationwide Availability45/100
Both Molecules45/100
Easy Cancellation54/100
Reputation58/100

Why it's a deal

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Read the fine print

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)

The bottom line

Best for: Shoppers who want brand-name-only GLP-1s without insurance in 42 states. myRocky is a Canadian-incorporated multi-product telehealth platform (Rocky Health Inc., Ontario) that markets brand-name GLP-1s — Ozempic, Mounjaro, and Wegovy — to US patients, with no compounded products.

Ranked #427 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to myRocky, out of 426 others we track.

Shopping myRocky against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs myRocky, and every program that undercuts or outscores it — starting with Shape Vantage, the closest match on score — is ranked on the myRocky alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from myRocky's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on myRocky's site. Not medical advice; see our disclosure.

Where myRocky ranks

See every program ranked by price →

← Back to all deals